What's the Better Dividend Stock Today: AbbVie or Pfizer?

AbbVie (NYSE: ABBV) and Pfizer (NYSE: PFE) are 2 apical healthcare stocks, and they're investments that tin make a ton of dividend income for your portfolio.

AbbVie, which yields 3.2%, has been a dividend maturation beast for decades and has been doing a bully occupation of increasing its concern adjacent aft its top-selling cause Humira mislaid patent protection. It has proven to beryllium a bully semipermanent dividend concern to bent connected to.

Pfizer offers a higher output of 6.7%, but it's a spot riskier, fixed that it's inactive successful the midst of trying to get backmost to maturation and is facing immoderate daunting patent cliffs successful the adjacent future. For investors, the pressing contented is whether the concern is connected the close way and if its dividend is so safe.

Below, I'll look astatine which of these dividend stocks is the amended enactment for income investors close now.

Is Pfizer's dividend truly safe?

The biggest question for income investors erstwhile analyzing these 2 stocks whitethorn travel down to the information of Pfizer's payout. Regardless of the yield, if the dividend is successful danger, what percent Pfizer pays contiguous whitethorn beryllium meaningless, and thus, AbbVie's banal would beryllium the amended enactment by default.

The problem, however, is that you can't conscionable look astatine Pfizer's payout ratio, which is implicit 100%, due to the fact that determination has been truthful overmuch sound successful its net successful caller quarters. The institution has gone done restructuring, and one-time expenses specified arsenic impairment charges person weighed connected its bottommost line.

Its escaped currency travel has totaled $9.5 cardinal implicit the past 4 quarters, which is simply a spot little than the $9.8 cardinal the institution has paid successful dividends during that clip frame. But with Pfizer trimming costs and looking to go leaner, that shortfall whitethorn not beryllium terribly concerning, astatine slightest not yet, anyway.

AbbVie's payout, connected the different hand, is acold much secure. The company's escaped currency has totaled astir $20 cardinal implicit the past 12 months, which is comfortably higher than the $11.8 cardinal it has paid successful dividends during that stretch.

AbbVie's dividend maturation could marque up for its lighter output

Although Pfizer's output is higher today, investors shouldn't place the imaginable for AbbVie's dividend income to rise. The institution has been generous with dividend increases implicit the years, and fixed however overmuch country it has successful its escaped currency flow, determination whitethorn beryllium immoderate much important increases to its dividend successful the coming years.